jonathan gOLDSTEIN

Jonathan is a Director, Corporate R&D and Ventures, at Boston Scientific Corporation (BSC), focusing on collaborations and investments in Europe and Israel. He has been working for BSC since 2012, initially interfacing with Israeli technology and projects, and generating collaborations across the spectrum of BSC’s R&D, Venture and Business Development functions. Jonathan manages the Corporate Research Division’s Worldwide Scouting Team, supporting Divisional and Corporate teams in identifying relevant next generation technologies and companies for the company’s pipeline.

Jonathan started out as a strategy consultant for Metapraxis Ltd. in London in the early 90s, working with blue-chip companies such as Unilever, Kleinwort Benson and S.G. Warburg. Since moving to Israel in 1995, he has focused on the biomedical field, working initially at one of Israel’s key hi-tech investment banks, followed by extensive periods in Business Development at some of Israel’s most innovative biomedical startups. Jonathan was as a member on the Advisory Board of the award-winning Meytav Technology Incubator, and, until recently, was the Israel Editor of Medical Device Daily of the US.

Jonathan holds a BSc. in Chemistry & Biochemistry from Imperial College, London, and an MBA from the University of London.